News The Post-Pandemic World of Antibiotics COVID-19 Antibiotics are cheap and common drugs used to treat bacterial infections.
Partner Content Partner Content Q&A with Team Consulting Ltd released for Injectable Drug De... Q&A with Team Consulting released for Injectable Drug
Events Partner Content SMi’s Inaugural Conference: Respiratory Drug Delivery 2019 Respiratory Drug Delivery Conference 2019
Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety Conference London 2018
Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety 2018
News GSK sets up Nucala and Dupixent showdown in COPD GSK has said new data leads it to believe Nucala will be "highly competitive" with rival biologic Dupixent in COPD - if it gets approved by the FDA.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl